These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 11464859

  • 1. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome.
    Brinkschmidt C, Christiansen H, Terpe HJ, Simon R, Lampert F, Boecker W, Dockhorn-Dworniczak B.
    Med Pediatr Oncol; 2001 Jan; 36(1):11-3. PubMed ID: 11464859
    [Abstract] [Full Text] [Related]

  • 2. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T, Sjöberg RM, Hedborg F, Kogner P.
    Cancer Res; 1995 Dec 01; 55(23):5681-6. PubMed ID: 7585654
    [Abstract] [Full Text] [Related]

  • 3. 17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group.
    Bown N, Lastowska M, Cotterill S, O'Neill S, Ellershaw C, Roberts P, Lewis I, Pearson AD, U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group.
    Med Pediatr Oncol; 2001 Jan 01; 36(1):14-9. PubMed ID: 11464868
    [Abstract] [Full Text] [Related]

  • 4. Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma.
    Spitz R, Hero B, Ernestus K, Berthold F.
    Clin Cancer Res; 2003 Oct 15; 9(13):4835-40. PubMed ID: 14581355
    [Abstract] [Full Text] [Related]

  • 5. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma.
    Bown N, Cotterill S, Lastowska M, O'Neill S, Pearson AD, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F, Nicholson J, Bernheim A, Betts DR, Vandesompele J, Van Roy N.
    N Engl J Med; 1999 Jun 24; 340(25):1954-61. PubMed ID: 10379019
    [Abstract] [Full Text] [Related]

  • 6. Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status.
    Cunsolo CL, Bicocchi MP, Petti AR, Tonini GP.
    Br J Cancer; 2000 Nov 24; 83(10):1295-300. PubMed ID: 11044353
    [Abstract] [Full Text] [Related]

  • 7. Comprehensive analysis of chromosome 1p deletions in neuroblastoma.
    Maris JM, Guo C, Blake D, White PS, Hogarty MD, Thompson PM, Rajalingam V, Gerbing R, Stram DO, Matthay KK, Seeger RC, Brodeur GM.
    Med Pediatr Oncol; 2001 Jan 24; 36(1):32-6. PubMed ID: 11464900
    [Abstract] [Full Text] [Related]

  • 8. Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations.
    Spitz R, Hero B, Westermann F, Ernestus K, Schwab M, Berthold F.
    Genes Chromosomes Cancer; 2002 Jul 24; 34(3):299-305. PubMed ID: 12007190
    [Abstract] [Full Text] [Related]

  • 9. Comparing histopathological classification with MYCN, 1p36 and 17q status detected by fluorescence in situ hybridisation from 14 untreated primary neuroblastomas in Singapore.
    Yong MH, Hwang WS, Knight LA, Fung W, Chan MY, Seow WT, Chui CH.
    Singapore Med J; 2009 Nov 24; 50(11):1090-4. PubMed ID: 19960166
    [Abstract] [Full Text] [Related]

  • 10. The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma.
    Gehring M, Berthold F, Edler L, Schwab M, Amler LC.
    Cancer Res; 1995 Nov 15; 55(22):5366-9. PubMed ID: 7585602
    [Abstract] [Full Text] [Related]

  • 11. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1.
    Hiyama E, Hiyama K, Ohtsu K, Yamaoka H, Fukuba I, Matsuura Y, Yokoyama T.
    Med Pediatr Oncol; 2001 Jan 15; 36(1):67-74. PubMed ID: 11464909
    [Abstract] [Full Text] [Related]

  • 12. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.
    Caron H, van Sluis P, de Kraker J, Bökkerink J, Egeler M, Laureys G, Slater R, Westerveld A, Voûte PA, Versteeg R.
    N Engl J Med; 1996 Jan 25; 334(4):225-30. PubMed ID: 8531999
    [Abstract] [Full Text] [Related]

  • 13. Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
    Hogarty MD, Maris JM, White PS, Guo C, Brodeur GM.
    Med Pediatr Oncol; 2001 Jan 25; 36(1):52-5. PubMed ID: 11464906
    [Abstract] [Full Text] [Related]

  • 14. Comparative genomic hybridization (CGH) analysis of neuroblastomas--an important methodological approach in paediatric tumour pathology.
    Brinkschmidt C, Christiansen H, Terpe HJ, Simon R, Boecker W, Lampert F, Stoerkel S.
    J Pathol; 1997 Apr 25; 181(4):394-400. PubMed ID: 9196436
    [Abstract] [Full Text] [Related]

  • 15. Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma.
    Spitz R, Hero B, Simon T, Berthold F.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3368-73. PubMed ID: 16740759
    [Abstract] [Full Text] [Related]

  • 16. Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.
    Spitz R, Hero B, Ernestus K, Berthold F.
    Clin Cancer Res; 2003 Jan 01; 9(1):52-8. PubMed ID: 12538451
    [Abstract] [Full Text] [Related]

  • 17. Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group.
    Lastowska M, Nacheva E, McGuckin A, Curtis A, Grace C, Pearson A, Bown N.
    Genes Chromosomes Cancer; 1997 Mar 01; 18(3):162-9. PubMed ID: 9071568
    [Abstract] [Full Text] [Related]

  • 18. FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma.
    Spitz R, Hero B, Ernestus K, Berthold F.
    Med Pediatr Oncol; 2003 Jul 01; 41(1):30-5. PubMed ID: 12764740
    [Abstract] [Full Text] [Related]

  • 19. Significance of chromosome 1p loss of heterozygosity in neuroblastoma.
    Maris JM, White PS, Beltinger CP, Sulman EP, Castleberry RP, Shuster JJ, Look AT, Brodeur GM.
    Cancer Res; 1995 Oct 15; 55(20):4664-9. PubMed ID: 7553646
    [Abstract] [Full Text] [Related]

  • 20. Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastoma.
    Spitz R, Betts DR, Simon T, Boensch M, Oestreich J, Niggli FK, Ernestus K, Berthold F, Hero B.
    Cancer Genet Cytogenet; 2006 May 15; 167(1):51-6. PubMed ID: 16682287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.